Skip to main content

LUTATHERA (Lutetium Lu 177 dotatate)

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

  • RegistryNCT05278208
  • PhasePhase 1/2
  • StatusRecruiting
  • ConditionHigh Grade Glioma
  • SponsorNationwide Children's Hospital
How LUTATHERA (Lutetium Lu 177 dotatate) worksNCT052782081 min

What the film says

Read the transcript

When a child's brain tumor returns after surgery, radiation, and chemotherapy, there is rarely a standard next step.

The idea: borrow a radioactive drug approved for adult gut tumors, and let it find brain tumors that share the same receptor.

Lutathera is a small peptide carrying lutetium-177. It binds a somatostatin receptor that most medulloblastomas, and some gliomas, ependymomas, and meningiomas, carry on their surface. A PET scan shows whether the tumor takes it up. If so, the drug goes in by vein every eight weeks, up to four times, and delivers radiation from inside the tumor.

Margot Lazow leads the trial from Nationwide Children's, with Philadelphia, Cincinnati, and Colorado, for ages four to thirty-nine. Safety first. Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT05278208

    Recurrent pediatric brain tumors lack a standard next step; Approved for adult gut (gastroenteropancreatic neuroendocrine) tumors; Peptide carrying lutetium-177; binds somatostatin receptor SST2A; Most medulloblastomas (75–100%), some HGG/ependymoma (13–80%), meningioma express it (+3 more lines)

The drug

What is being tested.

Lutathera: IV administration maximum dose of 200 mCi once every 8 weeks (one cycle) for total of 4 cycles (8 months)

Somatostatin receptors regulate cell growth through downstream modulation of both proliferation and apoptosis signaling pathways, and thus represent a potential therapeutic target. Lutathera (Lutetium [Lu]177 Dotatate) is a radionuclide therapy which binds type-2A somatostatin receptors (SST2A) and has recently gained FDA approval for the treatment of adult gastroenteropancreatic neuroendocrine tumors expressing SST2A.

High SST2A expression has been consistently observed in medulloblastoma and other embryonal tumors (75-100% of cases) as well as in some HGGs and anaplastic ependymomas (13-80%), with corresponding uptake on radiolabeled somatostatin receptor nuclear imaging (e.g. DOTATATE PET).

The study

How the trial runs.

This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS) tumors and meningiomas that demonstrate uptake on DOTATATE PET. The drug will be given intravenously once every 8 weeks for a total of up to 4 doses over 8 months in patients aged 4 to <12 years (Phase I) or 12 to </=39 years (Phase II) to test its safety and efficacy, respectively.

Funding Source - FDA OOPD (grant number FD-R-0532-01)

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • All participants must meet the following inclusion and

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.